589 related articles for article (PubMed ID: 28936969)
1. Systematic integration of biomedical knowledge prioritizes drugs for repurposing.
Himmelstein DS; Lizee A; Hessler C; Brueggeman L; Chen SL; Hadley D; Green A; Khankhanian P; Baranzini SE
Elife; 2017 Sep; 6():. PubMed ID: 28936969
[TBL] [Abstract][Full Text] [Related]
2. Integrative cancer pharmacogenomics to establish drug mechanism of action: drug repurposing.
El-Hachem N; Ba-Alawi W; Smith I; Mer AS; Haibe-Kains B
Pharmacogenomics; 2017 Nov; 18(16):1469-1472. PubMed ID: 29057710
[No Abstract] [Full Text] [Related]
3. Computational Methods for Drug Repurposing.
Rapicavoli RV; Alaimo S; Ferro A; Pulvirenti A
Adv Exp Med Biol; 2022; 1361():119-141. PubMed ID: 35230686
[TBL] [Abstract][Full Text] [Related]
4. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.
Firoozbakht F; Rezaeian I; Rueda L; Ngom A
BMC Bioinformatics; 2022 Apr; 23(1):143. PubMed ID: 35443626
[TBL] [Abstract][Full Text] [Related]
5. Omics Data Integration and Analysis for Systems Pharmacology.
Lim H; Xie L
Methods Mol Biol; 2019; 1939():199-214. PubMed ID: 30848463
[TBL] [Abstract][Full Text] [Related]
6. DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.
Issa NT; Kruger J; Wathieu H; Raja R; Byers SW; Dakshanamurthy S
BMC Bioinformatics; 2016 May; 17(1):202. PubMed ID: 27151405
[TBL] [Abstract][Full Text] [Related]
7. Systems biology based drug repositioning for development of cancer therapy.
Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
[TBL] [Abstract][Full Text] [Related]
8. Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
Sahu NU; Kharkar PS
Curr Top Med Chem; 2016; 16(19):2069-77. PubMed ID: 26881717
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
Wang Y; Yella J; Jegga AG
Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
[TBL] [Abstract][Full Text] [Related]
10. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
Alaimo S; Pulvirenti A
Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
[TBL] [Abstract][Full Text] [Related]
11. Computational biology approaches for drug repurposing.
Waseem T; Rajput TA; Mushtaq MS; Babar MM; Rajadas J
Prog Mol Biol Transl Sci; 2024; 205():91-109. PubMed ID: 38789189
[TBL] [Abstract][Full Text] [Related]
12. Computational drug repositioning using low-rank matrix approximation and randomized algorithms.
Luo H; Li M; Wang S; Liu Q; Li Y; Wang J
Bioinformatics; 2018 Jun; 34(11):1904-1912. PubMed ID: 29365057
[TBL] [Abstract][Full Text] [Related]
13. Knowledge graphs and their applications in drug discovery.
MacLean F
Expert Opin Drug Discov; 2021 Sep; 16(9):1057-1069. PubMed ID: 33843398
[TBL] [Abstract][Full Text] [Related]
14. REPRODUCIBLE DRUG REPURPOSING: WHEN SIMILARITY DOES NOT SUFFICE.
Guney E
Pac Symp Biocomput; 2017; 22():132-143. PubMed ID: 27896969
[TBL] [Abstract][Full Text] [Related]
15. eRepo-ORP: Exploring the Opportunity Space to Combat Orphan Diseases with Existing Drugs.
Brylinski M; Naderi M; Govindaraj RG; Lemoine J
J Mol Biol; 2018 Jul; 430(15):2266-2273. PubMed ID: 29237557
[TBL] [Abstract][Full Text] [Related]
16. Use of Computational Functional Genomics in Drug Discovery and Repurposing for Analgesic Indications.
Lötsch J; Kringel D
Clin Pharmacol Ther; 2018 Jun; 103(6):975-978. PubMed ID: 29350398
[TBL] [Abstract][Full Text] [Related]
17. Overcoming Sparseness of Biomedical Networks to Identify Drug Repositioning Candidates.
Poleksic A
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(4):2377-2384. PubMed ID: 33591920
[TBL] [Abstract][Full Text] [Related]
18. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
Zhao K; So HC
Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
[TBL] [Abstract][Full Text] [Related]
19. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
[TBL] [Abstract][Full Text] [Related]
20. Machine and deep learning approaches for cancer drug repurposing.
Issa NT; Stathias V; Schürer S; Dakshanamurthy S
Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]